Drug · DIN 02421666
ORAVERSE
FOR INTRAORAL SUBMUCOSAL INJECTION ONLY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 17, 2014; first marketed September 17, 2014.
- Drug Identification Number (DIN)
- 02421666
- Company (DIN owner)
- SeptodontSt-Maur-Des-Fosses, Val-De-Marne, France
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Submucosal
- Therapeutic class (ATC)
- Phentolamine V03AB36
- Class
- Human
- Record last updated
- September 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PHENTOLAMINE MESYLATE | 0.4 MG | 1.7 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 26, 2014: NOC 15334New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “oraverse”. A notice may cover another product or only some lots: read it to see what it covers.
- OraVerse: Distribution to wholesalers who do not hold an establishment license for sale of the product in CanadaNovember 13, 2025 · Drugs · Establishment/Site licensing · Type III
- OraVerse: Six wholesalers do not hold an establishment license for sale of the product in CanadaNovember 1, 2023 · Drugs · Establishment/Site licensing · Type III
- OraVerse Injection (2018-04-20)April 27, 2018 · Drugs · Product safety · Type III
- Oraverse (2015-01-02)January 14, 2015 · Drugs · Product safety · Type III
- Lignospan Standard and Oraverse (2014-12-12)December 23, 2014 · Drugs · Product safety · Type I